Difference between revisions of "Ibrutinib (PCI-32765)"
Jump to navigation
Jump to search
(Created page with "'''In clinical trials'''. ==General information== Class/mechanism: Irreversible inhibitor of Bruton's tyrosine kinase (BTK), which is an enzyme that participates in the B-cell r...") |
m (Redirected page to Ibrutinib (Imbruvica)) |
||
(4 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
− | + | #REDIRECT [[Ibrutinib (Imbruvica)]] | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− |
Latest revision as of 07:58, 3 January 2016
Redirect to: